Jinlin Guo

Title: Jinlin Guo: Innovator in Antibody Development

Introduction

Jinlin Guo is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of biotechnology. He holds a total of four patents, showcasing his innovative approach to developing antibodies for medical applications.

Latest Patents

Among his latest patents is the "Anti-human MASP-2 antibody, preparation method therefor and application thereof." This invention discloses an antibody that can bind to human MASP-2, demonstrating good biological activity in inhibiting the cleavage of C4 and the generation of C3b. This antibody has potential applications in treating MASP-2 related diseases, such as IgA nephropathy. Another notable patent is the "Anti-human interleukin-4 receptor alpha antibody and preparation method and application thereof." This invention reveals an antibody capable of binding to the human interleukin 4 receptor alpha (hIL-4R alpha), which can inhibit IL-4 and IL-13-induced cell line proliferation. This antibody is applicable in treating IL-4R alpha related diseases, including immune-mediated inflammatory diseases.

Career Highlights

Jinlin Guo has worked with several notable companies, including Shanghai Mabgeek Biotech Co., Ltd and Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. His work in these organizations has contributed to advancements in antibody research and development.

Collaborations

Some of his notable coworkers include Chenghai Zhang and Wei Dang, who have collaborated with him on various projects in the field of biotechnology.

Conclusion

Jinlin Guo's innovative work in antibody development has the potential to significantly impact the treatment of various diseases. His contributions to biotechnology exemplify the importance of research and innovation in improving healthcare solutions.